Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Amortization of Deferred Charges (2017 - 2024)

Historic Amortization of Deferred Charges for Mesa Laboratories (MLAB) over the last 8 years, with Q1 2024 value amounting to $234000.0.

  • Mesa Laboratories' Amortization of Deferred Charges rose 263.16% to $234000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $926000.0, marking a year-over-year increase of 209.48%. This contributed to the annual value of $990000.0 for FY2025, which is 691.14% up from last year.
  • Latest data reveals that Mesa Laboratories reported Amortization of Deferred Charges of $234000.0 as of Q1 2024, which was up 263.16% from $231000.0 recorded in Q4 2023.
  • In the past 5 years, Mesa Laboratories' Amortization of Deferred Charges ranged from a high of $1.4 million in Q1 2021 and a low of $221000.0 during Q2 2021
  • In the last 5 years, Mesa Laboratories' Amortization of Deferred Charges had a median value of $231000.0 in 2023 and averaged $563000.0.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first surged by 470.68% in 2020, then plummeted by 8361.25% in 2022.
  • Mesa Laboratories' Amortization of Deferred Charges (Quarter) stood at $1.4 million in 2020, then plummeted by 73.4% to $361000.0 in 2021, then tumbled by 37.12% to $227000.0 in 2022, then grew by 1.76% to $231000.0 in 2023, then rose by 1.3% to $234000.0 in 2024.
  • Its Amortization of Deferred Charges was $234000.0 in Q1 2024, compared to $231000.0 in Q4 2023 and $231000.0 in Q3 2023.